XML 27 R13.htm IDEA: XBRL DOCUMENT v3.25.0.1
Financial Instruments
12 Months Ended
Dec. 31, 2024
Investments, All Other Investments [Abstract]  
Financial Instruments

4. Financial Instruments

 

The following table summarizes the Company’s cash and cash equivalents, amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant category reported as cash and cash equivalents and restricted cash as of December 31, 2024 and 2023:

 

    December 31, 2024  
    Reported as:  
(in thousands)   Cash and Cash Equivalents     Restricted Cash- current     Short-term Investments     Restricted Cash  
Cash   $ 969     $ -     $ -     $ -  
Level 2                                
Money market funds     11,248       219       -       -  
Subtotal     11,248       219       -       -  
Total assets measured at fair value   $ 12,217     $ 219     $ -     $ -  

 

    December 31, 2023  
    Reported as:  
(in thousands)   Cash and Cash Equivalents     Restricted Cash- current     Short-term Investments     Restricted Cash  
Cash   $ 2,122     $ -     $ -     $ -  
Level 2                                
Money market funds     17,696       525       -       219  
Subtotal     17,696       525       -       219  
Total assets measured at fair value   $ 19,818     $ 525     $ -     $ 219  

 

Interest income recorded for these cash and investments was $0.7 million and $1.1 million during the years ended December 31, 2024, and December 31, 2023, respectively.

 

As of December 31, 2024 and 2023, the Company did not have any financial assets classified as Level 1.